VRTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $54,440,322.71

Vertex Pharmaceuticals Insider Trading History Chart

Vertex Pharmaceuticals Share Price & Price History

^$468.00

▼ -0.57 (-0.12%)

As of 09/6/2024 01:00 AM ET

Days: 30 | 90 | 365

Biden's Successor: The Radical Threat to YOUR Savings!

From Golden Crest | Ad

Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.

>> Get Your FREE Wealth Protection Guide <<

Vertex Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/30/2024	Jeffrey M. Leiden	Chairman	Sell	3,784	$499.00	$1,888,216.00	9,994
8/30/2024	Sangeeta N Bhatia	Director	Sell	646	$500.00	$323,000.00	4,435
8/7/2024	Carmen Bozic	CMO	Sell	2,280	$476.75	$1,086,990.00	23,259
8/1/2024	Bruce I. Sachs	Director	Sell	5,295	$508.00	$2,689,860.00	40,000
7/24/2024	Carmen Bozic	CMO	Sell	2,280	$488.46	$1,113,688.80	25,539
7/22/2024	Reshma Kewalramani	CEO	Sell	15,202	$497.00	$7,555,394.00	106,172
7/10/2024	Carmen Bozic	CMO	Sell	2,280	$487.34	$1,111,135.20	27,819
6/26/2024	Carmen Bozic	CMO	Sell	2,280	$471.72	$1,075,521.60	30,099
6/12/2024	Carmen Bozic	CMO	Sell	2,280	$478.00	$1,089,840.00	32,379
6/12/2024	E. Morrey Atkinson, III	EVP	Sell	7,288	$478.00	$3,483,664.00	15,972
5/30/2024	Ourania Tatsis	EVP	Sell	2,350	$439.11	$1,031,908.50	53,523
5/29/2024	Carmen Bozic	CMO	Sell	2,280	$445.56	$1,015,876.80	34,659
5/28/2024	Charles F. Wagner, Jr.	CFO	Sell	3,250	$454.79	$1,478,067.50	50,387
5/24/2024	Reshma Kewalramani	CEO	Sell	1,565	$457.00	$715,205.00	121,374
5/22/2024	Bruce I. Sachs	Director	Sell	7,073	$448.00	$3,168,704.00	40,000
2/26/2024	Ourania Tatsis	EVP	Sell	354	$425.70	$150,697.80	55,804
2/20/2024	Ourania Tatsis	EVP	Sell	480	$420.79	$201,979.20	59,827
2/12/2024	Amit Sachdev	EVP	Sell	3,222	$420.24	$1,354,013.28	74,364
2/12/2024	Jeffrey M. Leiden	Chairman	Sell	2,656	$419.51	$1,114,218.56	27,644
2/12/2024	Kristen Ambrose	CAO	Sell	1,374	$420.24	$577,409.76	9,676
2/12/2024	Stuart A. Arbuckle	COO	Sell	4,295	$420.24	$1,804,930.80	75,718
1/8/2024	Jeffrey M. Leiden	Chairman	Sell	6,648	$419.07	$2,785,977.36	2,423
11/6/2023	Bruce I. Sachs	Director	Sell	11,250	$385.00	$4,331,250.00	40,000
10/31/2023	Carmen Bozic	CMO	Sell	5,651	$355.92	$2,011,303.92	34,952
10/17/2023	Carmen Bozic	CMO	Sell	5,651	$373.25	$2,109,235.75	40,603
10/17/2023	Sangeeta N Bhatia	Director	Sell	243	$375.00	$91,125.00	3,901
10/16/2023	Jeffrey M. Leiden	Chairman	Sell	12,962	$374.00	$4,847,788.00	22,425
10/6/2023	Sangeeta N Bhatia	Director	Sell	242	$360.00	$87,120.00	4,144
10/3/2023	Carmen Bozic	CMO	Sell	5,651	$345.28	$1,951,177.28	46,254
10/2/2023	Jonathan Biller	EVP	Sell	610	$346.76	$211,523.60	10,569
9/19/2023	Carmen Bozic	CMO	Sell	5,651	$351.00	$1,983,501.00	51,905
8/23/2023	Ourania Tatsis	EVP	Sell	2,500	$355.00	$887,500.00	48,637
8/9/2023	David Altshuler	EVP	Sell	63	$345.51	$21,767.13	32,038
8/9/2023	Sangeeta N Bhatia	Director	Sell	242	$345.51	$83,613.42	4,386
7/17/2023	Bruce I. Sachs	Director	Sell	11,250	$356.75	$4,013,437.50	40,000
7/17/2023	Reshma Kewalramani	CEO	Sell	7,828	$355.00	$2,778,940.00	118,906
6/15/2023	Stuart A. Arbuckle	COO	Sell	8,603	$349.00	$3,002,447.00	56,556
5/30/2023	Kristen Ambrose	CAO	Sell	289	$329.82	$95,317.98	6,838
5/30/2023	Stuart A. Arbuckle	COO	Sell	82	$329.82	$27,045.24	56,556
5/8/2023	Bastiano Sanna	EVP	Sell	2,850	$350.00	$997,500.00	32,038
5/8/2023	Jeffrey M. Leiden	Chairman	Sell	1,125	$349.00	$392,625.00	35,387
5/5/2023	Bastiano Sanna	EVP	Sell	422	$350.03	$147,712.66	34,888
5/5/2023	Jeffrey M. Leiden	Chairman	Sell	879	$349.56	$307,263.24	36,512
5/2/2023	Bastiano Sanna	EVP	Sell	1,622	$350.66	$568,770.52	38,091
5/2/2023	Jeffrey M. Leiden	Chairman	Sell	6,450	$349.89	$2,256,790.50	41,899
5/2/2023	Sangeeta N Bhatia	Director	Sell	580	$348.28	$202,002.40	4,628
4/27/2023	Reshma Kewalramani	CEO	Sell	3,317	$339.08	$1,124,728.36	126,652
4/12/2023	Bastiano Sanna	EVP	Sell	7,567	$326.70	$2,472,138.90	39,713
4/12/2023	Bruce I. Sachs	Director	Sell	21,300	$326.73	$6,959,349.00	41,210
4/4/2023	Bastiano Sanna	EVP	Sell	522	$315.81	$164,852.82	47,280
3/24/2023	Charles F. Wagner, Jr.	CFO	Sell	1,768	$305.38	$539,911.84	49,611
3/17/2023	Charles F. Wagner, Jr.	CFO	Sell	2,000	$296.39	$592,780.00	51,379
3/16/2023	Bastiano Sanna	EVP	Sell	2,746	$300.59	$825,420.14	49,268
3/13/2023	Charles F. Wagner, Jr.	CFO	Sell	2,666	$293.83	$783,350.78	53,379
3/10/2023	Charles F. Wagner, Jr.	CFO	Sell	2,088	$289.61	$604,705.68	56,045
2/27/2023	Kristen Ambrose	CAO	Sell	1,207	$287.55	$347,072.85	7,303
2/27/2023	Ourania Tatsis	EVP	Sell	354	$287.48	$101,767.92	56,805
2/27/2023	Stuart A. Arbuckle	COO	Sell	5,034	$287.47	$1,447,123.98	56,556
2/22/2023	Stuart A. Arbuckle	COO	Sell	2,401	$294.33	$706,686.33	66,304
2/13/2023	Ourania Tatsis	EVP	Sell	275	$298.99	$82,222.25	65,765
2/13/2023	Stuart A. Arbuckle	COO	Sell	4,887	$298.92	$1,460,822.04	82,003
2/6/2023	David Altshuler	EVP	Sell	1,304	$306.00	$399,024.00	68,645
1/30/2023	Lloyd Carney	Director	Sell	2,700	$320.52	$865,404.00	4,150
1/27/2023	Yuchun Lee	Director	Sell	1,429	$322.03	$460,180.87	1,875
1/25/2023	Reshma Kewalramani	CEO	Sell	10,000	$315.05	$3,150,500.00	89,598
1/25/2023	Yuchun Lee	Director	Sell	4,000	$313.96	$1,255,840.00	1,875
1/23/2023	Yuchun Lee	Director	Sell	2,129	$312.02	$664,290.58	1,875
1/18/2023	Yuchun Lee	Director	Sell	442	$312.17	$137,979.14	1,875
11/7/2022	David Altshuler	EVP	Sell	1,303	$303.04	$394,861.12	36,077
10/24/2022	Sangeeta N Bhatia	Director	Sell	621	$310.00	$192,510.00	4,040
10/18/2022	Bastiano Sanna	EVP	Sell	1,791	$300.31	$537,855.21	39,192
8/15/2022	Joy Liu	SVP	Sell	3,747	$303.90	$1,138,713.30	9,605
8/15/2022	Reshma Kewalramani	CEO	Sell	11,689	$305.06	$3,565,846.34	99,598
8/15/2022	Stuart A. Arbuckle	COO	Sell	22,173	$303.93	$6,739,039.89	45,278
8/9/2022	Joy Liu	SVP	Sell	946	$300.00	$283,800.00	13,388
8/9/2022	Ourania Tatsis	EVP	Sell	1,400	$298.97	$418,558.00	46,090
8/9/2022	Stuart A. Arbuckle	COO	Sell	5,690	$300.67	$1,710,812.30	60,996
8/8/2022	Sangeeta N Bhatia	Director	Sell	621	$293.03	$181,971.63	4,661
7/29/2022	Sangeeta N Bhatia	Director	Sell	621	$278.77	$173,116.17	5,282
7/25/2022	Jeffrey M. Leiden	Chairman	Sell	132,079	$281.38	$37,164,389.02	2,423
7/19/2022	David Altshuler	EVP	Sell	17,865	$288.65	$5,156,732.25	36,077
6/24/2022	Reshma Kewalramani	CEO	Sell	11,689	$291.30	$3,405,005.70	111,153
5/4/2022	Bastiano Sanna	EVP	Sell	36	$275.09	$9,903.24	41,660
5/2/2022	Bastiano Sanna	EVP	Sell	320	$259.16	$82,931.20	41,696
5/2/2022	Charles F. Wagner, Jr.	CFO	Sell	343	$258.83	$88,778.69	42,730
5/2/2022	Sangeeta N Bhatia	Director	Sell	737	$258.94	$190,838.78	5,903
5/2/2022	Stuart A. Arbuckle	COO	Sell	306	$263.98	$80,777.88	64,760
4/29/2022	Joy Liu	SVP	Sell	120	$275.41	$33,049.20	14,334
4/25/2022	Kristen Ambrose	CAO	Sell	327	$269.55	$88,142.85	3,496
4/18/2022	Yuchun Lee	Director	Sell	2,000	$284.23	$568,460.00	1,875
4/13/2022	Jeffrey M. Leiden	Chairman	Sell	15,789	$289.04	$4,563,652.56	74,160
4/13/2022	Yuchun Lee	Director	Sell	2,000	$287.50	$575,000.00	1,875
4/11/2022	Yuchun Lee	Director	Sell	2,000	$280.30	$560,600.00	1,875
4/7/2022	Bastiano Sanna	EVP	Sell	561	$276.18	$154,936.98	42,782
4/7/2022	Yuchun Lee	Director	Sell	2,000	$274.86	$549,720.00	1,099
4/4/2022	Bastiano Sanna	EVP	Sell	562	$267.71	$150,453.02	43,343
4/4/2022	Yuchun Lee	Director	Sell	2,000	$267.72	$535,440.00	1,875
4/1/2022	Charles F. Wagner, Jr.	CFO	Sell	2,582	$264.76	$683,610.32	43,620
3/31/2022	Margaret G. McGlynn	Director	Sell	5,000	$262.27	$1,311,350.00	1,099
3/17/2022	Charles F. Wagner, Jr.	CFO	Sell	3,171	$250.15	$793,225.65
3/17/2022	Ourania Tatsis	EVP	Sell	2,833	$250.11	$708,561.63
2/25/2022	Ourania Tatsis	EVP	Sell	325	$230.95	$75,058.75
2/18/2022	Ourania Tatsis	EVP	Sell	519	$231.00	$119,889.00
2/11/2022	David Altshuler	EVP	Sell	2,297	$235.02	$539,840.94
2/2/2022	Bastiano Sanna	EVP	Sell	1,040	$250.98	$261,019.20
2/2/2022	Charles F. Wagner, Jr.	CFO	Sell	2,944	$250.07	$736,206.08
1/28/2022	Margaret G. McGlynn	Director	Sell	5,000	$241.79	$1,208,950.00
11/15/2021	Amit Sachdev	EVP	Sell	51	$187.19	$9,546.69
11/15/2021	Stuart A. Arbuckle	COO	Sell	3	$187.26	$561.78

Tim Sykes’ Urgent Trade Alert: “Make this move now”

From Timothy Sykes | Ad

WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…

Click here to see a unique election-year trade

SEC Filings (Institutional Ownership Changes) for Vertex Pharmaceuticals (NASDAQ:VRTX)

90.96% of Vertex Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vertex Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/6/2024	Cim LLC	2,947	$1.38M	0.2%	+1.4%	0.001%
9/5/2024	Sanctuary Advisors LLC	29,374	$13.77M	0.1%	N/A	0.011%
8/28/2024	Kestra Investment Management LLC	1,799	$0.84M	0.1%	N/A	0.001%
8/28/2024	Souders Financial Advisors	1,436	$0.67M	0.1%	+2.6%	0.001%
8/27/2024	Clearbridge Investments LLC	2,090,704	$979.96M	0.8%	-13.9%	0.810%
8/27/2024	Dana Investment Advisors Inc.	1,937	$0.91M	0.0%	-12.2%	0.001%
8/27/2024	New Wave Wealth Advisors LLC	913	$0.43M	0.2%	N/A	0.000%
8/27/2024	New Century Financial Group LLC	1,187	$0.56M	0.2%	-22.7%	0.000%
8/26/2024	Teachers Retirement System of The State of Kentucky	98,645	$46.24M	0.4%	-4.9%	0.038%
8/22/2024	Cetera Investment Advisers	52,013	$24.38M	0.1%	+2.3%	0.020%
8/22/2024	3Chopt Investment Partners LLC	7,942	$3.72M	1.1%	+1.6%	0.003%
8/21/2024	Advisory Alpha LLC	987	$0.46M	0.0%	+16.0%	0.000%
8/21/2024	Truist Financial Corp	218,641	$102.48M	0.2%	-2.0%	0.085%
8/19/2024	Chase Investment Counsel Corp	8,248	$3.87M	1.3%	+1.8%	0.003%
8/19/2024	EP Wealth Advisors LLC	4,909	$2.30M	0.0%	+4.2%	0.002%
8/19/2024	B. Riley Wealth Advisors Inc.	10,389	$4.87M	0.1%	+10.0%	0.004%
8/16/2024	Regal Investment Advisors LLC	2,056	$0.96M	0.1%	+3.7%	0.001%
8/16/2024	Northwestern Mutual Wealth Management Co.	15,942	$7.47M	0.0%	+92.2%	0.006%
8/16/2024	NewEdge Advisors LLC	13,632	$6.39M	0.0%	+5.5%	0.005%
8/16/2024	Northeast Financial Consultants Inc	5,962	$2.80M	0.1%	+0.4%	0.002%
8/16/2024	Copperwynd Financial LLC	4,506	$2.23M	0.7%	-5.7%	0.002%
8/16/2024	Creative Planning	79,117	$37.08M	0.0%	+5.3%	0.031%
8/16/2024	Ascent Group LLC	9,033	$4.23M	0.3%	+4.8%	0.004%
8/16/2024	Driehaus Capital Management LLC	1,169	$0.55M	0.0%	+25.2%	0.000%
8/16/2024	Kathmere Capital Management LLC	525	$0.25M	0.0%	-9.0%	0.000%
8/16/2024	Sepio Capital LP	7,095	$3.33M	0.3%	-0.6%	0.003%
8/16/2024	Raab & Moskowitz Asset Management LLC	1,786	$0.84M	0.2%	+2.8%	0.001%
8/15/2024	Peloton Wealth Strategists	575	$0.27M	0.1%	N/A	0.000%
8/15/2024	Susquehanna Portfolio Strategies LLC	1,206	$0.57M	0.0%	-88.7%	0.000%
8/15/2024	Susquehanna Fundamental Investments LLC	44,819	$21.01M	0.5%	N/A	0.017%
8/15/2024	Scientech Research LLC	8,933	$4.19M	0.9%	N/A	0.003%
8/15/2024	Legal & General Group Plc	2,422,677	$1.14B	0.3%	+1.2%	0.939%
8/15/2024	Lighthouse Investment Partners LLC	15,388	$7.21M	0.3%	N/A	0.006%
8/15/2024	Mackenzie Financial Corp	84,634	$39.67M	0.1%	-8.5%	0.033%
8/15/2024	The Manufacturers Life Insurance Company	633,575	$296.97M	0.3%	-8.9%	0.246%
8/15/2024	MBB Public Markets I LLC	18,114	$8.49M	0.2%	+2,398.5%	0.007%
8/15/2024	Daymark Wealth Partners LLC	782	$0.37M	0.0%	+38.9%	0.000%
8/15/2024	DE Burlo Group Inc.	48,565	$22.76M	3.1%	+21.3%	0.019%
8/15/2024	Deerfield Management Company L.P. Series C	1,276	$0.60M	0.0%	N/A	0.000%
8/15/2024	Decatur Capital Management Inc.	8,901	$4.17M	2.0%	+2.5%	0.003%
8/15/2024	Ameriprise Financial Inc.	2,054,781	$963.13M	0.3%	-7.7%	0.796%
8/15/2024	APG Asset Management N.V.	357,884	$156.52M	0.3%	+16.3%	0.139%
8/15/2024	APG Asset Management US Inc.	76,048	$35.84M	0.2%	+2.3%	0.029%
8/15/2024	AQR Capital Management LLC	536,114	$251.29M	0.4%	-19.6%	0.208%
8/15/2024	Armistice Capital LLC	36,059	$16.90M	0.2%	-30.6%	0.014%
8/15/2024	AXA S.A.	193,337	$90.62M	0.3%	-15.9%	0.075%
8/15/2024	AlTi Global Inc.	431	$0.20M	0.0%	-52.5%	0.000%
8/15/2024	Caxton Associates LP	3,500	$1.64M	0.1%	-39.3%	0.001%
8/15/2024	NBW Capital LLC	20,349	$9.54M	1.9%	-0.5%	0.008%
8/15/2024	Toronto Dominion Bank	131,106	$61.45M	0.1%	-14.3%	0.051%
8/14/2024	Fred Alger Management LLC	60,203	$28.22M	0.1%	+1.5%	0.023%
8/14/2024	Zurich Insurance Group Ltd FI	91,318	$42.80M	0.4%	N/A	0.035%
8/14/2024	Insigneo Advisory Services LLC	1,249	$0.60M	0.1%	+107.1%	0.000%
8/14/2024	Royal Capital Wealth Management LLC	429	$0.20M	0.2%	N/A	0.000%
8/14/2024	Sfmg LLC	7,845	$3.68M	0.3%	+0.8%	0.003%
8/14/2024	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	49,474	$23.19M	0.1%	+60.3%	0.019%
8/14/2024	Marshall Wace LLP	127,000	$59.53M	0.1%	-32.1%	0.049%
8/14/2024	Morse Asset Management Inc	10,115	$4.74M	1.1%	-0.8%	0.004%
8/14/2024	Xponance Inc.	47,695	$22.36M	0.2%	-19.3%	0.018%
8/14/2024	Bank of Montreal Can	511,428	$242.64M	0.1%	+0.9%	0.198%
8/14/2024	Lombard Odier Asset Management Europe Ltd	29,937	$14.03M	0.7%	N/A	0.012%
8/14/2024	Evergreen Capital Management LLC	2,636	$1.24M	0.0%	+9.1%	0.001%
8/14/2024	Public Sector Pension Investment Board	9,844	$4.61M	0.0%	+72.9%	0.004%
8/14/2024	Beck Capital Management LLC	1,966	$0.92M	0.3%	+4.2%	0.001%
8/14/2024	Harmony Asset Management LLC	6,140	$2.88M	1.2%	N/A	0.002%
8/14/2024	Altshuler Shaham Ltd	3,000	$1.41M	0.0%	-17.9%	0.001%
8/14/2024	Cyrus J. Lawrence LLC	26,488	$12.42M	2.5%	+93.1%	0.010%
8/14/2024	DRW Securities LLC	742	$0.35M	0.0%	-62.3%	0.000%
8/14/2024	EverSource Wealth Advisors LLC	598	$0.30M	0.0%	+5.8%	0.000%
8/14/2024	Gabelli Funds LLC	22,092	$10.36M	0.1%	-1.0%	0.009%
8/14/2024	Itau Unibanco Holding S.A.	164	$77K	0.0%	N/A	0.000%
8/14/2024	Fidelis Capital Partners LLC	5,180	$2.41M	0.3%	+77.2%	0.002%
8/14/2024	Epoch Investment Partners Inc.	186,029	$87.20M	0.4%	+3.8%	0.072%
8/14/2024	1832 Asset Management L.P.	4,630	$2.17M	0.0%	-19.9%	0.002%
8/14/2024	Frank Rimerman Advisors LLC	5,309	$2.49M	0.2%	+44,141.7%	0.002%
8/14/2024	Holderness Investments Co.	1,266	$0.59M	0.1%	+11.4%	0.000%
8/14/2024	ProShare Advisors LLC	269,741	$126.43M	0.3%	-10.2%	0.105%
8/14/2024	Profund Advisors LLC	29,546	$13.85M	0.5%	+12.1%	0.011%
8/13/2024	Kayne Anderson Rudnick Investment Management LLC	13,426	$6.29M	0.0%	-2.1%	0.005%
8/13/2024	Legacy Financial Advisors Inc.	2,423	$1.14M	0.2%	+5.1%	0.001%
8/13/2024	Ensign Peak Advisors Inc	183,704	$86.11M	0.2%	-18.2%	0.071%
8/13/2024	Nkcfo LLC	8,243	$3.86M	2.1%	-1.8%	0.003%
8/13/2024	Summit Trail Advisors LLC	2,881	$1.35M	0.0%	+14.8%	0.001%
8/13/2024	Thrivent Financial for Lutherans	94,794	$44.43M	0.1%	+6.5%	0.037%
8/13/2024	Sei Investments Co.	212,857	$99.77M	0.1%	-0.8%	0.082%
8/13/2024	Pacer Advisors Inc.	38,326	$17.96M	0.0%	+2.9%	0.015%
8/13/2024	Skandinaviska Enskilda Banken AB publ	218,833	$102.51M	0.5%	-17.4%	0.085%
8/13/2024	AE Wealth Management LLC	1,167	$0.55M	0.0%	-12.5%	0.000%
8/13/2024	ASB Consultores LLC	790	$0.37M	0.1%	-37.2%	0.000%
8/13/2024	Hollencrest Capital Management	295	$0.14M	0.0%	+51.3%	0.000%
8/13/2024	Waters Parkerson & CO. LLC	462	$0.22M	0.0%	N/A	0.000%
8/13/2024	Callan Capital LLC	4,440	$2.08M	0.2%	+2.5%	0.002%
8/13/2024	Canada Pension Plan Investment Board	337,116	$158.01M	0.2%	-12.8%	0.131%
8/13/2024	Davidson Capital Management Inc.	7,205	$3.38M	1.0%	+23.8%	0.003%
8/13/2024	Joseph Group Capital Management	4,817	$2.26M	1.2%	+9.7%	0.002%
8/13/2024	Public Employees Retirement Association of Colorado	428,720	$200.95M	0.8%	-0.2%	0.166%
8/13/2024	Benjamin F. Edwards & Company Inc.	5,892	$2.76M	0.0%	+18.8%	0.002%
8/13/2024	GM Advisory Group LLC	506	$0.24M	0.0%	-5.8%	0.000%
8/12/2024	Ieq Capital LLC	21,093	$9.89M	0.1%	+9.8%	0.008%
8/12/2024	Brighton Jones LLC	4,300	$2.02M	0.1%	+280.9%	0.002%

Data available starting January 2016

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people with CF for 6 years of age or older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 year or older who have CF with ivacaftor. The company's pipeline includes VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1 clinical trial; VX-548, a non-opioid medicine for the treatment of acute and neuropathic pain which is in Phase 3 clinical trial; Exa-cel, for the treatment of sickle cell disease and transfusion-dependent beta thalassemia which is in Phase 2/3 clinical trial. In addition, it provides inaxaplin for the treatment of APOL1-mediated focal segmental glomerulosclerosis and co-morbidities, such as hypertension which is in single Phase 2/3; VX- 880 and VX-264, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-970, which is in Phase 2 clinical trial for the treatment of cancer; and VX-803 and VX-984 for treatment of cancer in Phase 1 clinical trial. Further, it sells the products to specialty pharmacy and specialty distributors in the United States, as well as retail pharmacies, hospitals, and clinics. Additionally, the company has collaborations with CRISPR Therapeutics AG.; Moderna, Inc.; Entrada Therapeutics, Inc.; Arbor Biotechnologies, Inc.; Mammoth Biosciences, Inc.; and Verve Therapeutics., as well as collaborations with Tevard Biosciences to develop novel tRNA-based therapies for duchenne muscular dystrophy. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $468.00

$463.04

$471.89

50 Day Range

MA: $483.31

$464.51

$505.78

52 Week Range

Now: $468.00

$341.85

$510.64

Volume

1,090,355 shs

Average Volume

1,205,450 shs

Market Capitalization

$120.77 billion

P/E Ratio

30.37

Dividend Yield

N/A

Beta

0.4

Who are the company insiders with the largest holdings of Vertex Pharmaceuticals?: Vertex Pharmaceuticals' top insider shareholders include:
Reshma Kewalramani (CEO)
Stuart A Arbuckle (COO)
Amit Sachdev (EVP)
David Altshuler (EVP)
Ourania Tatsis (EVP)
Charles F Wagner Jr (CFO)
Carmen Bozic (CMO)
Bastiano Sanna (EVP)
Jeffrey M Leiden (Chairman)
Bruce I Sachs (Director)
Edward Morrow Atkinson III (EVP)
Jonathan Biller (EVP)
Kristen Ambrose (CAO)
Sangeeta N Bhatia (Director)
Lloyd Carney (Director)
Yuchun Lee (Director)
Learn More about top insider investors at Vertex Pharmaceuticals.
Who are the major institutional investors of Vertex Pharmaceuticals?: Vertex Pharmaceuticals' top institutional investors include:
Massachusetts Financial Services Co. MA — 1.06%
Legal & General Group Plc — 0.94%
Clearbridge Investments LLC — 0.81%
Ameriprise Financial Inc. — 0.80%
Bank of New York Mellon Corp — 0.71%
Renaissance Technologies LLC — 0.61%
Learn More about top institutional investors of Vertex Pharmaceuticals stock.
Which major investors are selling Vertex Pharmaceuticals stock?: Within the previous quarter, VRTX stock was sold by these institutional investors:
Clearbridge Investments LLC
Assenagon Asset Management S.A.
Ameriprise Financial Inc.
AQR Capital Management LLC
American Century Companies Inc.
Susquehanna International Group LLP
Jupiter Asset Management Ltd.
Victory Capital Management Inc.
In the last year, company insiders that have sold Vertex Pharmaceuticals company stock include:
Reshma Kewalramani (CEO)
Stuart A Arbuckle (COO)
Amit Sachdev (EVP)
David Altshuler (EVP)
Ourania Tatsis (EVP)
Charles F Wagner Jr (CFO)
Carmen Bozic (CMO)
Bastiano Sanna (EVP)
Jeffrey M Leiden (Chairman)
Bruce I Sachs (Director)
Edward Morrow Atkinson III (EVP)
Jonathan Biller (EVP)
Learn More investors selling Vertex Pharmaceuticals stock.
Which major investors are buying Vertex Pharmaceuticals stock?: During the previous quarter, VRTX stock was acquired by institutional investors including:
AMF Tjanstepension AB
Baillie Gifford & Co.
Manning & Napier Advisors LLC
Natixis Advisors LLC
Zurich Insurance Group Ltd FI
Dimensional Fund Advisors LP
Granite Bay Wealth Management LLC
APG Asset Management N.V.